EU Nephrologists Foresee Travere/CSL Vifor's FILSPARITM
Data from Spherix Global Insights second annual EU IgAN patient chart audit indicates that even with the EMA approval of FILSPARITM (sparsentan),...
United Kingdom Ionis Roche European Medicines Agency Spherix Network Spherix Global Insight Patient Chart
Source: globenewswire.com